Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study

被引：0

作者：

Ohoud Aljuhani

Khalid Al Sulaiman

Adel Alshabasy

Khalid Eljaaly

Abdulrahman I. Al Shaya

Haytham Noureldeen

Mohammed Aboudeif

Bodoor Al Dosari

Amina Alkhalaf

Ghazwa B. Korayem

Muneera M. Aleissa

Hisham A. Badreldin

Shmeylan Al Harbi

Abdullah Alhammad

Ramesh Vishwakarma

机构：

[1] King Abdulaziz University,Department of Pharmacy Practice, Faculty of Pharmacy

[2] King Abdulaziz Medical City,Pharmaceutical Care Department

[3] King Abdulaziz University,Department of Anesthesia and Intensive Care

[4] King Saud Bin Abdulaziz University for Health Sciences,College of Pharmacy

[5] King Abdullah International Medical Research Center,Pharmaceutical Care Department

[6] King Abdulaziz University Hospital,College of Pharmacy

[7] Princess Nourah Bint Abdulrahman University,Department of Clinical Pharmacy, College of Pharmacy

[8] King Saud University,College of Pharmacy

[9] University of Arizona,Department of Anesthesia and Intensive Care

[10] Brigham and Women’s Hospital,undefined

[11] Ain Shams University,undefined

来源：

BMC Infectious Diseases | / 21卷

关键词：

COVID-19; SARS-Cov-2; Tocilizumab; Secondary infection; CRE; Critically ill; Intensive care units (ICUs); Immunomodulatory drugs;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
Roddy, John
Wells, Daniel
Schenck, Katharine
Santosh, Shrihari
Santosh, Sadashiv
CRITICAL CARE EXPLORATIONS, 2022, 4 (05)
[22] Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study
Al Harbi, Shmeylan
Kensara, Raed
Aljuhani, Ohoud
Korayem, Ghazwa B.
Altebainawi, Ali F.
Al Harthi, Abdullah
Vishwakarma, Ramesh
Alenazi, Alaa M.
Almutairi, Abdulmajed
Alshaya, Omar
Alraddadi, Sultan
Al Sulaiman, Tareq
Aldakkan, Latifah
Mahboob, Reem
Alaamer, Kholoud
Alissa, Abdulrahman
Hafiz, Awatif
Aldhayyan, Nada
Althewaibi, Sara
Alenezi, Farhan
Alkhotani, Nadeen Y.
Alghamdi, Sara A.
Alenazi, Abeer A.
Al Sulaiman, Khalid
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
[23] Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study
Jiang, Saiping
Wang, Rongrong
Li, Lu
Hong, Dongsheng
Ru, Renping
Rao, Yuefeng
Miao, Jing
Chen, Na
Wu, Xiuhua
Ye, Ziqi
Hu, Yunzhen
Xie, Minghua
Zuo, Minjuan
Lu, Xiaoyang
Qiu, Yunqing
Liang, Tingbo
FRONTIERS IN MEDICINE, 2020, 7
[24] Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study
Fan, Siyuan
Xiao, Meng
Han, Fei
Xia, Peng
Bai, Xiaoyin
Chen, Huan
Zhang, Hongmin
Ding, Xin
Zhao, Hua
Zhao, Jing
Sun, Xuefeng
Jiang, Wei
Wang, Chunyao
Cao, Wei
Guo, Fan
Tian, Ran
Gao, Peng
Wu, Wei
Ma, Jie
Wu, Dong
Liu, Zhengyin
Zhou, Xiang
Wang, Jinglan
Guan, Tianjia
Qin, Yan
Li, Taisheng
Xu, Yingchun
Zhang, Dong
Chen, Yu
Xie, Jing
Li, Yongzhe
Yan, Xiaowei
Zhu, Yicheng
Peng, Bin
Cui, Liying
Zhang, Shuyang
Guan, Hongzhi
FRONTIERS IN NEUROLOGY, 2020, 11
[25] Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
Al Sulaiman, Khalid
Aljuhani, Ohoud
Korayem, Ghazwa B.
Altebainawi, Ali
Alharbi, Reham
Assadoon, Maha
Vishwakarma, Ramesh
Ismail, Nadia H.
Alshehri, Asma A.
Al Mutairi, Faisal E.
Alfaifi, Mashael
Alharthi, Abdullah F.
Alenazi, Abeer A.
Alalawi, Mai
Al Zumai, Omar
Al Haji, Hussain
Al Dughaish, Sarah T.
Alawaji, Abdulrahman S.
Alhaidal, Haifa A.
Al Ghamdi, Ghassan
BMC PULMONARY MEDICINE, 2023, 23 (01)
[26] The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study
Al Sulaiman, Khalid
Aljuhani, Ohoud
Korayem, Ghazwa B.
Altebainawi, Ali F.
Vishwakarma, Ramesh
Alfaifi, Mashael
Alsohimi, Samiah
Alrayes, Aljoharah
Albishi, Sara
Alqahtani, Reem
Alalawi, Mai
Al Sulaihim, Ibrahim
Alanazi, Thamer A.
Alqahtani, Rahaf A.
Almagthali, Alaa
Jomah, Shahamah
Alshlowi, Areej
Alshammari, Tahani R.
Alzahrani, Shahad S.
Abdulqader, Marwa I.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
[27] The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study
Al Sulaiman, Khalid
Aljuhani, Ohoud
Korayem, Ghazwa B.
Altebainawi, Ali F.
Vishwakarma, Ramesh
AlFaifi, Mashael
Alsohimi, Samiah
Alrayes, Aljoharah
Albishi, Sara
Alqahtani, Reem
Alalawi, Mai
Al Sulaihim, Ibrahim
Alanazi, Thamer A.
Alqahtani, Rahaf A.
Almagthali, Alaa
Jomah, Shahamah
Alshlowi, Areej
Alshammari, Tahani R.
Alzahrani, Shahad S.
Abdulqader, Marwa I.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
[28] The burden of nosocomial superinfections in a retrospective cohort study of critically ill COVID-19 patients
Anne Kathrin Lösslein
Paulina Ines Staus
Cynthia Beisert Carneiro
Martin Wolkewitz
Georg Häcker
BMC Infectious Diseases, 25 (1)
[29] Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study
Bartoszewicz, Mateusz
Czaban, Slawomir Lech
Bartoszewicz, Klaudia
Kuzmiuk, Damian
Ladny, Jerzy Robert
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2023, 10
[30] Association of nitrogen balance trajectories with clinical outcomes in critically ill COVID-19 patients: A retrospective cohort study
Dupuis, Claire
Bret, Alexandre
Janer, Alexandra
Guido, Olivia
Bouzgarrou, Radhia
Dopeux, Loic
Hernandez, Gilles
Mascle, Olivier
Calvet, Laure
Thouy, Francois
Grapin, Kevin
Couhault, Pierre
Kinda, Francis
Laurichesse, Guillaume
Bonnet, Benjamin
Adda, Mireille
Boirie, Yves
Souweine, Bertrand
CLINICAL NUTRITION, 2022, 41 (12) : 2895 - 2902

← 1 2 3 4 5 →